Lv5
820 积分 2025-08-21 加入
pH-Triggered Aggregation of Polylysine Nanoparticles Enhances TNF-α siRNA Delivery for Rheumatoid Arthritis Therapy
2个月前
已完结
Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment
2个月前
已完结
The secret ally: immunostimulation by anticancer drugs
3个月前
已完结
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
3个月前
已完结
Initial Treatment of Burns of the Hand
5个月前
已关闭
Luo H, et al. Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial. JAMA. 2021;326(10):916-925
5个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
5个月前
已完结
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
5个月前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
5个月前
已完结
皖公网安备34019202002308
